Get started
Author

Ayman Askari

Observed names: A. Askari, AYMAN ASKARI, Askari A., Askari, Ayman
Observed institutions: Royal National Hospital for Rheumatic Diseases, North Bristol NHS Trust, University of Leeds, Jordan University of Science and Technology, Leeds Teaching Hospitals NHS Trust, Newcastle upon Tyne Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Robert Jones and Agnes Hunt Orthopaedic Hospital, Royal Hampshire County Hospital, Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust, University of Bath, Keele University, University of Birmingham, University of Sheffield
ORCID: 0000-0001-9414-7350
Observed ORCID: 0000-0001-9414-7350
OpenAlex ID: A5029912499
Intra-articular injection of mesenchymal stem cells leads to reduced inflammation and cartilage damage in murine antigen-induced arthritis
2014 · Oksana Kehoe, Alison Cartwright, et al. · Journal of Translational Medicine · 99
PDF
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study
2014 · W. Tillett, G. Shaddick, et al. · Lara D. Veeken · 86
Orphan receptor GPR15/BOB is up-regulated in rheumatoid arthritis
2014 · Alison Cartwright, Caroline Schmutz, et al. · Cytokine · 30
PDF
Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis
2016 · William Tillett, Gavin Shaddick, et al. · Lara D. Veeken · 28
Evaluation of Pathergy Test in North Jordan
2000 · A. Askari, M. Al-Aboosi, et al. · Clinical Rheumatology · 14
Internuclear Ophthalmoplegia and Horner's Syndrome Due to Presumed Giant Cell Arteritis
1993 · Ayman Askari, O M P Jolobe, et al. · Journal of the Royal Society of Medicine · 12
PDF
Ankylosing spondylitis in north Jordan: descriptive and analytical study
2000 · Ayman Askari, Muawyah D Al-Bdour, et al. · Annals of the Rheumatic Diseases · 10
PDF
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease
2023 · Peter C. Taylor, Ayman Askari, et al. · BMC Medicine · 7
PDF
Basic Science * 208. Stem Cell Factor Expression is Increased in the Skin of Patients with Systemic Sclerosis and Promotes Proliferation and Migration of Fibroblasts in vitro
2013 · S. Karrar, X. Shiwen, et al. · Lara D. Veeken · 5
Primary tuberculous appendicitis
1993 · Ayman Askari, Peter Coventry, et al. · Postgraduate Medical Journal · 5
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study
2023 · Marc Schmalzing, Herbert Kellner, et al. · Advances in Therapy · 4
PDF
Janus Kinase Enzyme (jak) Inhibitors and Rheumatoid Arthritis: a Review of the Literature
2019 · AYMAN ASKARI, ABDULLA KHALID NOURI, et al. · International Journal of Current Pharmaceutical Research · 4
PDF
Case Reports * 1. A Late Presentation of Loeys-Dietz Syndrome: Beware of TGF Receptor Mutations in Benign Joint Hypermobility
2013 · P. Mehta, S. Holder, et al. · Lara D. Veeken · 4
Spontaneous Pneumothorax in a Patient with Systemic Lupus Erythematosus and Recent Infection with Coronavirus
2022 · Nicholas Graves, Julia Flint, et al. · Case Reports in Pulmonology · 3
PDF
Clinical and Real-World Evidence on Etanercept Biosimilar Switching: A Narrative Literature Review of Efficacy and Safety
2025 · Marc Schmalzing, Ayman Askari, et al. · Advances in Therapy · 2
PDF
Ab0419 Outcomes of the Self-injection Assessment Questionnaire in Rheumatoid Arthritis, Axial Spondyloarthritis and Psoriatic Arthritis Patients Receiving Gp2015 (etanercept Biosimilar) in a Real-world Study: Final Results From Compact Study
2023 · M. Schmalzing, A. Askari, et al. · Annals of the Rheumatic Diseases · 2
PDF
Exploring the Efficacy and Safety of Cannabis in the Management of Fibromyalgia
2022 · AMOL SAGDEO, AYMAN ASKARI, et al. · International Journal of Current Pharmaceutical Research · 2
PDF
Cytokines and inflammatory mediators: 25. Certolizumab Pegol has a Different Profile from the other Anti-TNFS, Including Golimumab, in a Variety of in Vitro Assays
2011 · A. Nesbitt, G. Fossati, et al. · Lara D. Veeken · 2
Microscopic polyangiitis presenting as schizophrenia
1999 · A. Askari, A. Saadeh, et al. · Rheumatology International · 2
Pos0640 Real-world Effectiveness and Safety of Gp2015 in Patients With Rheumatic Diseases: Final Results of the Compact Study
2022 · M. Schmalzing, H. Kellner, et al. · Annals of the Rheumatic Diseases · 1
PDF
Pos0608 Switching of Treatment From Reference Etanercept to Sandoz Etanercept Biosimilar in Patients With Rheumatic Diseases: an Interim Analysis of Real-world Data From the Compact Study
2021 · M. Schmalzing, A. Askari, et al. · Annals of the Rheumatic Diseases · 1
Baricitinib in Rheumatoid Arthritis – Real World Cross-Sectional Study
2020 · Amol Sagdeo, Ayman Askari, et al. · The Open Rheumatology Journal · 1
PDF
Steroid-Sparing Agents in Giant Cell Arteritis
2019 · Amol Sagdeo, Ayman Askari, et al. · The Open Rheumatology Journal · 1
PDF
Complex lupus management: when multiple organs demand precision
2025 · Hirushi S. Jayasekera, Ayman Askari, et al. · Clinical Medicine
Normal creatinine-kinase levels in post-COVID myositis: insights into localised muscle involvement
2025 · Hirushi S. Jayasekera, Mahmoud Elshehawy, et al. · Clinical Medicine
Works count: 34
Citation count: 325
H-index: 7
I10-index: 7
Year
Topic
Type